can you breastfeed on tirzepatide Alexandra Sowa, MD | A big win for women's health: low-dose (2.5mg + 5mg) has now been deemed safe in breastfeeding. 🍼✨ Breastfeeding is vital for 🚨 New Research Alert: Tirzepatide

Approved after the review call

Myth: Results are permanent Fact: Maintenance sessions are needed Myth: Completely safe for everyone Fact: Not suitable for certain medical conditions Myth: Works instantly Fact: Takes weeks of consistent treatment It is generally safe when administered by a qualified medical professional, but risks exist if misused

Expect monitoring

Updated phase 3 titration pathway The phase 3 schedule uses the following escalation: Weeks 1-4: 2mg weekly Weeks 5-8: 4mg weekly Weeks 9-12: 8mg weekly Week 13+: Maintenance dose (4mg, 9mg, or 12mg depending on assignment) The introduction of a 9mg dose option is interesting

ACP's target and kill cancer cells via different mechanisms, including membrane disruption, pore formation, induction of apoptosis, necrosis, autophagy, and regulation of the immune system